Rheumatology News
- Drugmaker Partners Launch Copycat for Arthritis Drug Humira
- Family Docs Provide Most Care for Several Chronic Diseases
- Review Finds Biosimilars for Psoriasis Safe, Effective
- Colchicine for Excess ASCVD Risk in IMIDs? Experts Weigh In
- Systemic Sclerosis Without Skin Fibrosis Can Still Be Severe
- SJS/TEN: Study Addresses Issues in Identifying Culprit Drug
- Hepatitis B Vaccination Rates Lag in Patients With Psoriasis
- FDA Decision on Bimekizumab Approval for Psoriasis Delayed
- CAR T-Cell Therapy May Treat Antisynthetase Syndrome
- New AAP Framework for Spotting Problems in Premature Babies
- Study Identifies Possible Pathogenesis of Rare Skin Disorder
- UnitedHealth to Add Humira Biosimilar to Reimbursement List
- New Law Allows International Graduates to Skip US Residency
- Low-Dose Colchicine Approved for CVD: Now What?
- You Can Dismiss a Difficult Patient, but Should You?
- Proposal to Cap Part B Pay on Some Drugs Draws Opposition
- Alert FDA OKs Low-Dose Colchicine for Broad CV Indication
- Systemic JIA and AOSD Are the Same Disease, EULAR Says
- Methotrexate Does Not Impair Sperm Quality
- EULAR 2023 EULAR Issues Imaging Recommendations for Gout, CPPD